Machine Learning-Based Accurate Analysis of cTnI With Alphalisa Immunoassay Enabled Centrifugal Microfluidic System
https://www.embs.org/tnb/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
Transactions on NanoBioscience (TNB)
//www.embs.org/tnb/wp-content/uploads/sites/16/2022/06/ieee-tnb-logo2x.png
Cardiac troponin (cTnI) is a biomarker with high sensitivity and specificity for acute myocardial infarction (AMI). Rapid and accurate detection of cTnI can effectively reduce the mortality of AMI. Aiming…
read more